Living with spasticity can feel like your body is fighting against you. For many people, it manifests as stiff, tight muscles that resist movement, or sudden, uncontrollable spasms that can be painful and embarrassing. Simple tasks like walking, picking up an object, or even finding a comfortable sleeping position can become daily challenges. This condition, often resulting from stroke, multiple sclerosis, cerebral palsy, or spinal cord injuries, creates a constant tension that can limit independence and mobility.

Treatment is critical not only to relieve pain but to prevent long-term complications such as permanent muscle shortening (contractures) or skin breakdown. The goal is to relax the muscles enough to improve function and comfort without making them so loose that they become weak. Because spasticity varies widely from mild stiffness in one arm to severe tightness in the legs, treatment plans are highly individualized. Doctors assess the underlying cause and the specific muscles involved before recommending medication (National Institute of Neurological Disorders and Stroke, 2023).

Overview of treatment options for Spasticity

The management of spasticity generally follows a stepped approach. Physical therapy and stretching are the foundation, but medications are almost always necessary when stiffness interferes with daily life or sleep. The primary goal of medical treatment is to reduce abnormal muscle tone and the frequency of spasms.

Medical interventions are categorized based on whether the spasticity is generalized (affecting the whole body or large areas) or focal (affecting specific muscles). For generalized spasticity, oral medications are typically prescribed. For focal issues, injections are often the preferred method. In severe, chronic cases where oral medications fail or cause too many side effects, surgical implantation of a medication pump may be considered to deliver drugs directly to the spinal fluid.

Medications used for Spasticity

For generalized spasticity, skeletal muscle relaxants are the standard first-line treatment. Baclofen is the most commonly prescribed medication in this class. It is widely used for spasticity related to spinal cord injury and multiple sclerosis. Clinical experience suggests that while effective, finding the right dose often requires a gradual increase to balance relief against side effects.

Tizanidine is another frequently used oral medication. It is often chosen for patients who need relief but want to avoid the significant muscle weakness that can sometimes occur with other drugs.

Benzodiazepines, such as diazepam or clonazepam, are also effective muscle relaxants. However, due to their sedating nature and potential for dependency, they are often reserved for nighttime use or short-term relief.

Dantrolene is a unique medication often used as a second-line option, particularly for patients who have suffered a stroke. Unlike the others, it acts directly on the muscle tissue rather than the nervous system.

For focal spasticity, injections of onabotulinumtoxinA (botulinum toxin) are the gold standard. These injections target specific tight muscles, such as a clenched fist or a stiff ankle. Patients can expect relief to begin within a few days of the injection, with benefits lasting approximately three months before retreatment is needed (Mayo Clinic, 2023).

How these medications work

Most oral spasticity medications act on the central nervous system. Baclofen and tizanidine reduce overactive nerve signals in the spinal cord and brain, allowing muscles to relax.

Benzodiazepines enhance the calming effect of the neurotransmitter GABA on the nervous system, including muscle control pathways. Dantrolene works uniquely by blocking calcium release inside muscle fibers, which prevents forceful contraction. Botulinum toxin temporarily paralyzes specific muscles by blocking the nerve-to-muscle chemical signal (American Association of Neurological Surgeons, 2024).

Side effects and safety considerations

Common side effects of oral spasticity medications include drowsiness/sedation (affecting driving/work) and muscle weakness, which can increase the risk of falls if beneficial stiffness is lost.

Baclofen carries a specific risk: never stop abruptly, as sudden withdrawal can cause seizures and hallucinations. Tizanidine requires blood pressure and liver function monitoring due to potential effects. Dantrolene also risks liver toxicity.

Botulinum toxin injections are generally safe, possibly causing temporary weakness in nearby muscles or flu-like symptoms. Seek immediate medical care for difficulty breathing or swallowing, which signals a severe reaction or overdose. Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. American Association of Neurological Surgeons. https://www.aans.org
  2. Mayo Clinic. https://www.mayoclinic.org
  3. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov
  4. MedlinePlus. https://medlineplus.gov

Medications for Spasticity

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Spasticity.

Found 6 Approved Drugs for Spasticity

Baclofen

Brand Names
Ozobax, Lyvispah, Lioresal, Fleqsuvy, Gablofen

Baclofen

Brand Names
Ozobax, Lyvispah, Lioresal, Fleqsuvy, Gablofen
Baclofen tablets USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen tablet treatment will aid in restoring residual function. Baclofen tablets USP may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen tablets in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions.

OnabotulinumtoxinA

Brand Names
Jeuveau, Dysport, Botox, Xeomin, Daxxify

OnabotulinumtoxinA

Brand Names
Jeuveau, Dysport, Botox, Xeomin, Daxxify
DYSPORT is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for: The treatment of cervical dystonia in adults.

TiZANidine

Brand Names
Tizanidne, Zanaflex, Ontralfy

TiZANidine

Brand Names
Tizanidne, Zanaflex, Ontralfy
TizanidineTablets, USP is a central alpha-2-adrenergic agonist indicated for themanagement of spasticity. Because of the short duration of therapeutic effect,treatment with Tizanidine Tablets, USP should be reserved for those dailyactivities and times when relief of spasticity is most important [ see Dosage andAdministration.

Dantrolene

Brand Names
Dantrium, Revonto, RYANODEX Dantrolene

Dantrolene

Brand Names
Dantrium, Revonto, RYANODEX Dantrolene
In Chronic Spasticity: Dantrolene sodium is indicated in controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis). It is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. Such patients must have presumably reversible spasticity where relief of spasticity will aid in restoring residual function. Dantrolene sodium is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. If improvement occurs, it will ordinarily occur within the dosage titration, and will be manifested by a decrease in the severity of spasticity and the ability to resume a daily function not quite attainable without dantrolene sodium. Occasionally, subtle but meaningful improvement in spasticity may occur with dantrolene sodium therapy. In such instances, information regarding improvement should be solicited from the patient and those who are in constant daily contact and attendance with him. Brief withdrawal of dantrolene sodium for a period of 2 to 4 days will frequently demonstrate exacerbation of the manifestations of spasticity and may serve to confirm a clinical impression. A decision to continue the administration of dantrolene sodium on a long-term basis is justified if introduction of the drug into the patient's regimen: produces a significant reduction in painful and/or disabling spasticity such as clonus, or permits a significant reduction in the intensity and/or degree of nursing care required, or rids the patient of any annoying manifestation of spasticity considered important by the patient himself. In Malignant Hyperthermia: Oral dantrolene sodium is also indicated preoperatively to prevent or attenuate the development of signs of malignant hyperthermia in known, or strongly suspect, malignant hyperthermia susceptible patients who require anesthesia and/or surgery. Currently accepted clinical practices in the management of such patients must still be adhered to (careful monitoring for early signs of malignant hyperthermia, minimizing exposure to triggering mechanisms and prompt use of intravenous Dantrolene Sodium and indicated supportive measures should signs of malignant hyperthermia appear); see also the package insert for Dantrium ® (dantrolene sodium) Intravenous. Oral dantrolene sodium should be administered following a malignant hyperthermic crisis to prevent recurrence of the signs of malignant hyperthermia.

Intensol

Brand Names
TaperDex 12-day, Dextenza, Maxidex, TaperDex 6-day, Hemady, Ozurdex, RAYOS, Valtoco

Intensol

Brand Names
TaperDex 12-day, Dextenza, Maxidex, TaperDex 6-day, Hemady, Ozurdex, RAYOS, Valtoco
Diazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis. As an adjunct prior to endoscopic procedures if apprehension, anxiety or acute stress reactions are present, and to diminish the patient's recall of the procedures. Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma); spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff-man syndrome; and tetanus. Diazepam Injection is a useful adjunct in status epilepticus. Diazepam is a useful premedication (the intramuscular route is preferred) for relief of anxiety and tension in patients who are to undergo surgical procedures. Intravenously, prior to cardioversion for the relief of anxiety and tension and to diminish the patient's recall of the procedure.
Showing 1-5 of 6
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances